Skip to main content
Journal cover image

Plasma des-acyl ghrelin, but not plasma HMW adiponectin, is a useful cardiometabolic marker for predicting atherosclerosis in elderly hypertensive patients.

Publication ,  Journal Article
Yano, Y; Toshinai, K; Inokuchi, T; Kangawa, K; Shimada, K; Kario, K; Nakazato, M
Published in: Atherosclerosis
June 2009

OBJECTIVE: The coming obesity epidemic in elderly persons necessitates the establishment of new and easy-to-use cardiometabolic markers to identify individuals most likely to develop atherosclerosis among hypertensives. METHODS: We measured plasma HMW adiponectin and des-acyl ghrelin levels, and carotid-artery intima-media thickness (cIMT) in 263 elderly hypertensives (mean 72.6 years; 37%men). Other cardiometabolic markers, including metabolites, inflammation, and hemostasis, were also measured. RESULTS AND CONCLUSION: Both HMW adiponectin and des-acyl ghrelin levels were inversely correlated with obesity. The HMW adiponectin level was favorably associated with glucose and lipid metabolites, PAI-1 (all P<0.05), and hs-CRP (P=0.07) after adjustment for age, sex, and BMI; however, it had no correlations with cIMT. In contrast, although there were no correlations between des-acyl ghrelin and cardiometabolic markers, except for a positive association with the nitrite/nitrate (NO(x)) level (P=0.002), des-acyl ghrelin had a significant inverse correlation with cIMT (P=0.003). A multivariable regression analysis showed that des-acyl ghrelin, but not HMW adiponectin, was significantly associated with cIMT after adjusting for age, obesity, sex, smoking, 24-h BP, and other cardiometabolic factors (beta=-0.178, P=0.001). Moreover, the increased risk of cIMT among those with abdominal obesity compared with non-obesity (0.833+/-0.185 mm vs. 0.782+/-0.163 mm, P=0.019) was explained by the elevated 24-h BP and reduced des-acyl ghrelin level, but not by other cardiometabolic parameters. These associations were unchanged after adding NO(x) to the model. In conclusion, the des-acyl ghrelin level is a useful cardiometabolic marker for predicting atherosclerosis in elderly hypertensives, and the pathologic pathway linking these factors is independent of its NO bioactivity.

Duke Scholars

Published In

Atherosclerosis

DOI

EISSN

1879-1484

Publication Date

June 2009

Volume

204

Issue

2

Start / End Page

590 / 594

Location

Ireland

Related Subject Headings

  • Ultrasonography
  • Risk Factors
  • Risk Assessment
  • Regression Analysis
  • Predictive Value of Tests
  • Plasminogen Activator Inhibitor 1
  • Obesity
  • Nitrites
  • Nitrates
  • Molecular Weight
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Yano, Y., Toshinai, K., Inokuchi, T., Kangawa, K., Shimada, K., Kario, K., & Nakazato, M. (2009). Plasma des-acyl ghrelin, but not plasma HMW adiponectin, is a useful cardiometabolic marker for predicting atherosclerosis in elderly hypertensive patients. Atherosclerosis, 204(2), 590–594. https://doi.org/10.1016/j.atherosclerosis.2008.10.013
Yano, Yuichiro, Koji Toshinai, Takashi Inokuchi, Kenji Kangawa, Kazuyuki Shimada, Kazuomi Kario, and Masamitsu Nakazato. “Plasma des-acyl ghrelin, but not plasma HMW adiponectin, is a useful cardiometabolic marker for predicting atherosclerosis in elderly hypertensive patients.Atherosclerosis 204, no. 2 (June 2009): 590–94. https://doi.org/10.1016/j.atherosclerosis.2008.10.013.
Yano Y, Toshinai K, Inokuchi T, Kangawa K, Shimada K, Kario K, et al. Plasma des-acyl ghrelin, but not plasma HMW adiponectin, is a useful cardiometabolic marker for predicting atherosclerosis in elderly hypertensive patients. Atherosclerosis. 2009 Jun;204(2):590–4.
Yano, Yuichiro, et al. “Plasma des-acyl ghrelin, but not plasma HMW adiponectin, is a useful cardiometabolic marker for predicting atherosclerosis in elderly hypertensive patients.Atherosclerosis, vol. 204, no. 2, June 2009, pp. 590–94. Pubmed, doi:10.1016/j.atherosclerosis.2008.10.013.
Yano Y, Toshinai K, Inokuchi T, Kangawa K, Shimada K, Kario K, Nakazato M. Plasma des-acyl ghrelin, but not plasma HMW adiponectin, is a useful cardiometabolic marker for predicting atherosclerosis in elderly hypertensive patients. Atherosclerosis. 2009 Jun;204(2):590–594.
Journal cover image

Published In

Atherosclerosis

DOI

EISSN

1879-1484

Publication Date

June 2009

Volume

204

Issue

2

Start / End Page

590 / 594

Location

Ireland

Related Subject Headings

  • Ultrasonography
  • Risk Factors
  • Risk Assessment
  • Regression Analysis
  • Predictive Value of Tests
  • Plasminogen Activator Inhibitor 1
  • Obesity
  • Nitrites
  • Nitrates
  • Molecular Weight